All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • Market intelligence reports
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 16, 2019
Home » Topics » Science

Science
%{topic} RSS Feed RSS

Nanoparticles make microfractures visible on color CT

November 25, 2019
By Annette Boyle
No Comments
Hafnium nanoparticles that home onto microfractures in bone make the tiny cracks visible in spectral or color computed tomography (CT) imaging. Researchers at the University of Illinois at Urbana-Champaign and the University of Maryland created the nanotechnology to work in conjunction with spectral molecular imaging developed by New Zealand-based MARS Bioimaging Ltd. (MBI). The research appeared in Advanced Functional Materials.
Read More
Science-AST--2511.png
Genotype and phenotype

‘PhASTer’ susceptibility testing could improve antibiotic use, trials

November 25, 2019
By Anette Breindl
No Comments
One necessary step to fend off a dystopian future of medical care without antibiotics is the development of new antibiotics. Another is improved deployment of existing ones, a feat which will take, among other things, better antibiotic susceptibility testing (AST). 
Read More

Australian researchers create kidney tissue from iPS cells

November 25, 2019
By Tamra Sami
No Comments
MELBOURNE, Australia – Researchers at the Murdoch Children’s Research Institute in Melbourne are pushing the boundaries on creating kidney tissue from stem cells.
Read More

Bioworld MedTech’s Cardiology Extra

November 25, 2019
By Liz Hollis
No Comments
Keeping you up to date on recent developments in cardiology.
Read More
Test-tube-dropper-research

Bench Press for Nov. 22, 2019

November 22, 2019
By Anette Breindl
No Comments
BioWorld looks at translational medicine.
Read More

Bioworld MedTech’s Neurology extra

November 22, 2019
By Andrea Applegate and Anette Breindl
No Comments
Keeping you up to date on recent developments in neurology.
Read More

Bioworld MedTech’s Diagnostics extra

November 21, 2019
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech's Orthopedics Extra

November 20, 2019
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More
aging hands

Double-duty CD4+ T cells may hold key to longevity

November 19, 2019
By John Fox
No Comments
Researchers at the RIKEN Center for Integrative Medical Science (IMS) and Keio University School of Medicine (KUSM) in Japan have discovered that people ages 110 or longer, the so-called supercentenarians, have elevated blood levels of CD4+ cytotoxic T lymphocytes (CTLs).
Read More

BioWorld MedTech's Oncology Extra

November 19, 2019
By Mark McCarty
No Comments
Keeping you up to date on recent developments in oncology.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 14 15 Next

Popular Stories

  • Bioworld MedTech’s Oncology Extra

    BioWorld MedTech
    Keeping you up to date on recent developments in oncology.
  • Ear-disorders

    FDA gives thumbs up to Cochlear’s implantable bone conduction hearing system

    BioWorld MedTech
    The U.S. FDA has cleared Cochlear Ltd.’s newest cochlear implant, the Osia 2 system, an active implantable bone conduction hearing system. Unlike Cochlear’s...
  • Drugs-pills-global-map-

    Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity

    BioWorld
    LONDON – It’s no secret that American citizens pay the most for drugs, but the extent of the disparity is laid bare in a new index of the prices of 13 medicines...
  • Frankyoung-11-27

    Buoyed by optimism and love of family, former FDA chief Frank Young leaned into storms

    BioWorld
    Commissioner of the FDA for five years starting in 1984, Frank Young relished his position “at the vortex of controversy” as he sought to deal with the AIDS...
  • Biopharma companies continue their strong momentum in November

    BioWorld
    After being in the doldrums for the majority of the year, public biopharmaceutical companies, it appears, have turned the corner and are now on a major upswing.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Archives
    • Contact us
    • Cookie policy
    • Copyright notice
    • Privacy policy
    • Share your news
    • Staff
    • Terms of use
Follow Us

Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing